Skip to Content
Merck
All Photos(1)

Key Documents

View All Documentation

301515

Sigma-Aldrich

N-Tritylglycine

98%

Synonym(s):

N-(Triphenylmethyl)glycine

Sign Into View Organizational & Contract Pricing

Select a Size

10 G
€125.00

€125.00

Estimated to ship onApril 13, 2025

Request a Bulk Order
All Photos(1)

Select a Size

Change View
10 G
€125.00

About This Item

Linear Formula:
(C6H5)3CNHCH2CO2H
CAS Number:
5893-05-0
Molecular Weight:
317.38
MDL number:
MFCD00004276
UNSPSC Code:
12352209
PubChem Substance ID:
24858195
NACRES:
NA.22

€125.00

Estimated to ship onApril 13, 2025

Request a Bulk Order

Quality Level

100

Assay

98%

form

powder

reaction suitability

reaction type: solution phase peptide synthesis

application(s)

peptide synthesis

SMILES string

OC(=O)CNC(c1ccccc1)(c2ccccc2)c3ccccc3

InChI

1S/C21H19NO2/c23-20(24)16-22-21(17-10-4-1-5-11-17,18-12-6-2-7-13-18)19-14-8-3-9-15-19/h1-15,22H,16H2,(H,23,24)

InChI key

XUXRXWLKUYPGMZ-UHFFFAOYSA-N

Application

N-protected glycine for the preparation of peptides.[1][2]

Storage Class Code

11 - Combustible Solids

WGK

WGK 3

Flash Point(F)

Not applicable

Flash Point(C)

Not applicable

Personal Protective Equipment

dust mask type N95 (US), Eyeshields, Gloves

Choose from one of the most recent versions:

Certificates of Analysis (COA)

Lot/Batch Number
STBH8179
07713LN
01604CP
03103CP
S15998

Don't see the Right Version?

If you require a particular version, you can look up a specific certificate by the Lot or Batch number.

Search for a COA

Already Own This Product?

Find documentation for the products that you have recently purchased in the Document Library.

Visit the Document Library

Tetrahedron, 40, 1869-1869 (1984)
Synthesis, 219-219 (1984)
Hiraku Onishi et al.
Biological & pharmaceutical bulletin, 37(10), 1641-1649 (2014-10-03)
Chondroitin sulfate-glycyl-prednisolone conjugate (CS-GP) was previously demonstrated to exhibit superior anti-arthritic effects compared to prednisolone (PD) alone. In this study, CS-GP was examined for its pharmacokinetic features and tropism for inflammatory joints using rats with adjuvant-induced arthritis in order to
Atsushi Tamura et al.
Journal of biomaterials science. Polymer edition, 28(10-12), 1124-1139 (2017-03-17)
We developed stimuli-labile polyrotaxanes (PRXs) composed of β-cyclodextrin (β-CD), Pluronic as an axle polymer, and acid-cleavable N-triphenylmethyl groups as bulky stopper molecules, and found that the PRXs are potent therapeutics for Niemann-Pick type C disease, because the PRX can effectively

Questions

Reviews

No rating value

Active Filters

Our team of scientists has experience in all areas of research including Life Science, Material Science, Chemical Synthesis, Chromatography, Analytical and many others.

Contact Technical Service